Chennai, November 18: Shares of Caplin Point Laboratories plunged more than 7% in intraday trading today after the United States Food and Drug Administration (US FDA) flagged concerns at its Gummidipoondi, Tamil Nadu plant. The US FDA inspection at the plant concluded with 10 procedural observations, though this did not have any impact on the company’s operations. 

The inspection, conducted between August 13 and August 21, concluded with the USFDA  finding observations that led to the plant being classified as Official Action Indicated (OAI).

The plant manufactures sterile injectables, ophthalmics, and complex formulations and is run by Caplin Point’s subsidiary Caplin Steriles Limited. Despite the classification downgrade, company management clarified that day-to-day manufacturing operations, production schedules, and product shipments remain ongoing

“The observations are procedural in nature and do not pertain to data integrity, and none of them were repeat observations,” the company said in a statement, adding that it does not anticipate any immediate material financial or operational disruptions to its ongoing business.

The Gummidipoondi facility, also known as CP-IV, is one of Caplin’s key facilities and plays an integral role in its market expansion plans, especially after the company acquired 10 ANDAs from an unnamed generic manufacturer in January this year.

Caplin Point hit an all time high in September 2026 and has been viewed as a promising company for a long time. The stock closed at ₹2,070.90 when markets closed on November 18. The company’s shares have risen 15% this year so far.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Readers should conduct their own research or consult with a qualified financial advisor before making any investment decisions.

Abizar has been writing before AI started to take over your lives! His expertise lies in analysing diverse perspectives and simplifying them for laymen. Beyond writing, storytelling and editing, he enjoys running, learning and enjoying the outdoors.

HEgoogleNews